Work

Experts in FUE technique

The FUE technique is the last great advance as it eliminate the scar of the donor area and the physical and aesthetic trauma that represents

Work
Work

Weekly videos

Every week we publish the most recent cases and information related to hair transplant

Work
Team

Team

Professional, friendly, ready

DRLOReNZODEF

DR. JOSÉ LORENZO

MEDICAL DIRECTOR · CHIEF SURGEON CAPILAR UNIT
equipo-1300x867

MEDILOR Team

pilarlorenzo3

PILAR LORENZO

GENERAL MANAGER
Team

Avant-garde

We are at the forefront of capillary research, developing new techniques and procedures, collaborating
permanently with the best surgeons, clinics and institutions in the world.

Work

Avanced hair
restoration center

We use the best modern technology along with the most advanced techniques under the advice of prestigious surgeons and highly qualified health care personnel. We are backed by 15 years of research and more than 2,000 patients operated. Here you can see a samples of our last works

Real results

100%
Work
Services

Medical treatments

2013 update

Finasteride

Battered and bruised, finasteride’s image has been tarnished by accusations ranging from inciting prostate cancer, depression, and permanent sexual adverse effects to stimulating male breast cancer.

Finasteride

The position of the ISHRS on Finasteride

Since 1998, Finasteride (Propecia) has been used by millions of men to treat androgenic alopecia successfully and with a relatively low rate of side effects.

Read

Finasteride and cancer of the prostate

An study that we find interesting about the influence of Finasteride 5 mg (Proscar® and similar) in the development of prostate cancer,

Learn more

Evaluation of sexual function in patients taking Finasteride

1 mg Finasteride 1 mg (PROPECIA) has been approved in the USA and in the majority of European countries for the treatment of androgenic alopecia in its early stages in men. The main concern that many doctors and patients have about this drug is the possible

Read more

External therapy: Minoxidil

Minoxidil was approved in 1988 by the American FDA for use in males in a 2% solution, and in 1991 for use in women at the same concentration.

Read

Dudas y consultas

If you have any questions about our services, please contact us.

Contact

ICC don’t support any hair transplant forum. We are members of the WFI (Work FUE Institute)

ICC does not share ISHRS criteria 

Services
News

Recent news

Recent news

News